Investment Q&A

Q: I have held JNJ for years and I am *STILL* holding on , in the [vain] hope that surely management will FINALLY resolve its various self-inflicted legal problems. I have been MISERABLY wrong. JNJ shares continue to decline (drowning is the perception as we focus much more on loss). I was idiot enough to buy into JNJ’s spin off KVUE, on which I have a rather loss in just one year.

Notwithstanding the enthusiasm of media commentators, the health care sector hasn’t done anything outside of a couple of star-companies. Are JNJ and KVUE worth holding on to? I would appreciate very much your substance-backed reasons either way. In your answer, kindly please put less emphasis on the legal issues which are already well known and focus entirely on the future prospects .
Many thanks.

Q: WHICH CONSUMER STOCK MONDELEZ OR KENVUE WOULD BE BETTER NOW AND GOING FORWARD FOR THE FUTURE?

Q: MONDELEZ OR KENVUE WHICH ONE WOULD YOU TAKE FOR THE PRESENT AND FUTURE? ALSO, THE REASONS FOR PICKING THE ONE YOU DID?

Q: Hi 5i,

I want to add 1 of the following consumer related US companies to an income portfolio with some growth:

COST (good growth, very small dividend)
WMT (good growth, small dividend)
AMZN (Good growth, No dividend)
KVUE (good products, good dividend, not as much growth)

Please review them, rank them in order of preference for a long term hold. If you have a better alternative, please include it.

Please deduct 5 credits, 1 for each company and 1 for the other possibility.

I look forward to your review.
John

Q: I have a largish position in JNJ and see there is an offer to exchange some or all for a stake in KVUE at a 7% market discount which puts cost close to the IPO price of KVUE based on July 24 AM market price.

What to do - exchange some or all, ignore or buy KVUE separately rather than end up with a likely odd lot?

Q: Which of JNJ and GILD do you think is the better quality company for a long term investment? In response to other readers questions, you seem to like GILD, but I worry about its dependence on HIV drugs. Is it diversified enough? JNJ seems more diversified, but I worry about its talc liabilities and slow growth. Will JNJ be a stronger company after the Kenvue spin-off?

Q: How do current shareholders of JNJ benefit from the spinoff of Kenvue? Thank you for clarifying.

Q: What does your crystal ball say about this spin off company?